Source: M&A Times

Tetra Discovery: Shionogi acquires Tetra, a US drug research and development company

Shionogi [4507] announced that it will acquire all shares of Tetra Therapeutics (hereinafter "Tetra") and make it a wholly owned subsidiary.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Chad A. Coberly's photo - CEO of Tetra

CEO

Chad A. Coberly

CEO Approval Rating

90/100

Read more